Radiopharmaceuticals in cardiology
نویسندگان
چکیده
منابع مشابه
Radiopharmaceuticals for nuclear cardiology: radiation dosimetry, uncertainties, and risk.
UNLABELLED The technical basis for the dose estimates for several radiopharmaceuticals used in nuclear cardiology is reviewed, and cases in which uncertainty has been encountered in the dosimetry of an agent are discussed. Also discussed is the issue of uncertainties in radiation dose estimates and how to compare the relative risks of studies. METHODS Radiation dose estimates (organ absorbed ...
متن کاملRadiopharmaceuticals in monitoring cancer
122 patients who presented with or developed calcification within metastatic ovarian cancer. Changes in soft tissue lesion size and the development of calcification have been correlated with histopathology and outcome. The study group was compared with a control group of 1577 patients who had a CT scan performed at least once during follow-up. A positive relationship between calcification and t...
متن کاملNuclear cardiology in Iran in 2002 [Persian]
Aim: Few nuclear cardiology surveys were published in the literature, mostly from developed countries. The aim of this study is to perform a nuclear cardiology survey in Iran. This may lead to better decision making and programming. Methods and Materials: A questionnaire was sent by mail or e-mail to all nuclear medicine centers in Iran asking for details of nuclear cardiology practice in...
متن کاملPET Radiopharmaceuticals
PET (Positron Emission Tomography) is a powerful imaging technique through which quantitative information on the distribution of positron emitter labeled radiopharmaceuticals (PET radiopharmaceuticals) in the body can be realized. Positrons (β +) are positively charged beta particles. They are emitted when the atom is proton enriched. A positron has only a transient existence. After losing all ...
متن کاملPET Radiopharmaceuticals
PET (positron emission tomography) is a powerful imaging technique that can provide quantitative information on the distribution of positron emitter labeled radiopharmaceuticals (PET radiopharmaceuticals) in the body. Positrons (ß+) are positively charged beta particles. They are emitted when the atom is proton rich. A positron has only a transient existence. After losing all of its kinetic ene...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Nuclear Medicine Review
سال: 2012
ISSN: 1506-9680
DOI: 10.5603/nmr.2012.0008